Page last updated: 2024-08-23

etoposide and Neoplasm Metastasis, Unknown Primary

etoposide has been researched along with Neoplasm Metastasis, Unknown Primary in 44 studies

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's18 (40.91)18.2507
2000's17 (38.64)29.6817
2010's8 (18.18)24.3611
2020's1 (2.27)2.80

Authors

AuthorsStudies
Afchain, P; Baudin, E; Desgrippes, R; Hadoux, J; Hautefeuille, V; Lepage, C; Lorgis, V; Monterymard, C; Scoazec, JY; Thuillier, F; Tougeron, D; Walter, T1
Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A1
Barbera, MA; Biasco, G; Bondi, A; Brandi, G; Brighi, N; Campana, D; Corbelli, J; Pantaleo, MA; Paragona, M1
Abe, H; Hashimoto, T; Kato, T; Mizukami, T; Ohata, T; Takahashi, T1
Ishihara, M; Katayama, N; Mizuno, T; Oda, H; Okano, M; Saito, K; Tamaru, S; Yamashita, Y1
Hamano, Y; Hyodo, I; Moriwaki, T; Sakashita, S; To, K; Watahiki, T; Yamada, T1
Chohnabayashi, N; Ishikawa, G; Jinta, T; Kitamura, A; Mochizuki, S; Nishimura, N; Suzuki, K; Tomishima, Y; Yamano, Y1
Dray, M; Mweempwa, A; Tan, A1
Chao, TK; Hou, WC; Kao, CC; Lai, YJ; Li, HM; Su, HY; Yu, MH1
Azad, A; Chionh, F; Lee, C1
Druck, P; Gupta, P; Iwamoto, C; Mesa, H; Niehans, GA; Rawal, A; Rezcallah, A1
Krüger, I; Lindenfelser, R; Scherwitz, P1
Abad, A; Balaña, C; Cirauqui, B; Font, A; Manzano, JL; Mate, JL; Moreno, I; Rosell, R1
Barceló, R; Ferreiro, J; Fuente, N; López Vivanco, G; Muñoz, A; Rubio, I1
Cardarelli, N; Carle, F; Cellerino, R; Cetto, GL; Contu, A; D'Aprile, M; Fedeli, SL; Fiorentini, G; Gesuita, R; Giorgi, F; Montironi, R; Nortilli, R; Parziale, AP; Piga, A1
Burris, HA; Erland, JB; Greco, FA; Hainsworth, JD; Hermann, R; Litchy, S; Morrissey, LH; Rodriguez, GI; Shaffer, DW; Yardley, DA1
Cardillo, F; Carle, F; Catalano, V; Cellerino, R; Cetto, G; Gesuita, R; Giorgi, F; Montironi, R; Nortilli, R; Piga, A; Porfiri, E; Riva, N1
Alberts, SR; Erlichman, C; Furth, A; Lathia, CD; Molina, JR; Reid, JM; Safgren, SL; Sloan, JA1
De Braud, F; Di Meglio, G; Fazio, N; Grana, C; Lorizzo, K; Pelosi, G; Torrisi, R; Tradati, N1
Chiba, N; Gamoh, M; Ishioka, C; Kakudo, Y; Kato, S; Murakawa, Y; Nishino, Y; Ohori, H; Ohtsuka, K; Sakayori, M; Shibata, H; Shimodaira, H; Suzuki, T; Takahashi, M; Takahashi, S; Yamaura, G; Yasuda, K; Yoshioka, T1
Hop, WC; Planting, AS; Stoter, G; van der Gaast, A; Verweij, J1
Bosl, GJ; Chaganti, RS; Mazumdar, M; Motzer, RJ; Reuter, VE; Rodriguez, E1
Henzen-Logmans, SC; Planting, AS; Stoter, G; van der Gaast, A; Verweij, J1
de Campos, ES; Harris, M; Menasce, LP; Radford, J; Thatcher, N1
Chen, YM; Kuo, BI; Liu, JM; Perng, RP; Tsai, CM; Wang, SY; Whang-Peng, J1
Erland, JB; Greco, FA; Hainsworth, JD; Kalman, LA; Schreeder, MT1
Greco, FA; Hainsworth, JD3
Amano, T; Hatori, S; Imada, T; Ito, H; Kondo, J; Maehara, T; Rino, Y; Shiozawa, M; Suzuki, Y; Takahashi, M1
Chang, J; Chow, W; Correia, J; Dancey, J; Dulude, H; Franssen, E; Gallant, G; Girouard, M; Goel, R; Verma, S; Warner, E1
Chao, Y; Chen, LT; Chen, YM; Chiou, TC; Hsieh, RK; Liu, JM; Liu, SM; Tiu, CM; Whang-Peng, J; Wu, HW1
de Mulder, PH; de Wit, R; Louwerens, M; Rodenhuis, S; Schornagel, J; Verweij, J1
Burris, HA; Erland, JB; Gray, JR; Greco, FA; Hainsworth, JD; Kalman, LA; Schreeder, MT1
Dowell, JE; Garrett, AM; Hande, KR; Johnson, DH; Shyr, Y1
Lasset, C; Merrouche, Y; Negrier, S; Peaud, PY; Rebattu, P; Trillet-Lenoir, V; Voog, E1
Borel, C; Ducreux, M; Fizazi, K; Le Chevalier, T; Ruffié, P; Saghatchian, M; Théodore, C1
Culine, S; Cupissol, D; Fabbro, M; Pinguet, F; Romieu, G; Ychou, M1
Greco, FA; Hainsworth, JD; Johnson, DH3
Prins, E; Splinter, TA; Van Der Gaast, A; Verwey, J1
Henzen-Logmans, SC; Rodenburg, CJ; Stoter, G; van der Gaast, A; Verweij, J1
Abbruzzese, JL; Faintuch, J; Frost, P; Raber, MN; Sumrall, C1

Reviews

2 review(s) available for etoposide and Neoplasm Metastasis, Unknown Primary

ArticleYear
The evolving role of paclitaxel for patients with carcinoma of unknown primary site.
    Seminars in oncology, 1999, Volume: 26, Issue:1 Suppl 2

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Etoposide; Humans; Neoplasms, Unknown Primary; Paclitaxel

1999
The role of etoposide in the treatment of poorly differentiated carcinoma of unknown primary site.
    Cancer, 1991, Jan-01, Volume: 67, Issue:1 Suppl

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Etoposide; Humans; Neoplasms, Unknown Primary

1991

Trials

19 trial(s) available for etoposide and Neoplasm Metastasis, Unknown Primary

ArticleYear
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2021, Volume: 53, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Neuroendocrine; Etoposide; Female; Fluorouracil; Humans; Intestinal Neoplasms; Irinotecan; Leucovorin; Male; Neoplasm Metastasis; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Oxaliplatin; Pancreatic Neoplasms; Platinum Compounds; Progression-Free Survival; Prospective Studies; Quality of Life; Stomach Neoplasms; Survival Rate; Treatment Outcome

2021
A phase II study of cisplatin, etoposide and gemcitabine in an unfavourable group of patients with carcinoma of unknown primary site.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms, Unknown Primary

2003
[Prognostic and predictive factors of patients with cancer of unknown origin treated with a paclitaxel-based chemotherapy].
    Medicina clinica, 2004, Feb-21, Volume: 122, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Predictive Value of Tests; Prognosis; Survival Rate

2004
Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site.
    British journal of cancer, 2004, May-17, Volume: 90, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Treatment Outcome

2004
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.
    The oncologist, 2004, Volume: 9, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Treatment Outcome

2004
Identification of clinical prognostic factors in patients with unknown primary tumors treated with a platinum-based combination.
    Oncology, 2005, Volume: 69, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms, Unknown Primary; Patient Selection; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome

2005
A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin.
    Anti-cancer drugs, 2005, Volume: 16, Issue:9

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biphenyl Compounds; Carboplatin; Cohort Studies; Colonic Neoplasms; Enzyme Inhibitors; Etoposide; Female; Humans; Male; Matrix Metalloproteinase Inhibitors; Melanoma; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Neutropenia; Organic Chemicals; Phenylbutyrates; Thrombocytopenia; Thymoma; Treatment Outcome; Vomiting

2005
Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Prognosis; Remission Induction

1995
Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary site.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:9

    Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary

1993
Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE).
    Cancer, 1994, Jan-15, Volume: 73, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Unknown Primary; Retrospective Studies; Vincristine

1994
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:6

    Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Humans; Liver Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis

1997
One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site.
    Seminars in oncology, 1997, Volume: 24, Issue:6 Suppl 19

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Survival Rate; Treatment Outcome

1997
A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS).
    British journal of cancer, 1998, Volume: 77, Issue:12

    Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary

1998
Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEP.
    International journal of cancer, 1999, Dec-10, Volume: 83, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Germinoma; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Testicular Neoplasms

1999
A randomized Phase II trial in patients with carcinoma of an unknown primary site.
    Cancer, 2001, Feb-01, Volume: 91, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Treatment Outcome

2001
Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primary.
    American journal of clinical oncology, 2000, Volume: 23, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Survival Analysis

2000
Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation--results of a prospective study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Differentiation; Cisplatin; Etoposide; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Interferon-alpha; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies

2001
Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary site.
    Cancer, 2002, Feb-01, Volume: 94, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Treatment Outcome

2002
Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Fluorouracil; Humans; Middle Aged; Neoplasms, Unknown Primary; Remission Induction; Survival Rate

1991

Other Studies

23 other study(ies) available for etoposide and Neoplasm Metastasis, Unknown Primary

ArticleYear
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.
    World neurosurgery, 2017, Volume: 104

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2017
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.
    Journal of chemotherapy (Florence, Italy), 2018, Volume: 30, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Retrospective Studies; Stomach Neoplasms

2018
[A Case of Biopsy Confirmed Unresectable Retroperitoneal Seminoma Successfully Treated with Chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasms, Unknown Primary; Retroperitoneal Neoplasms; Seminoma

2017
[A Case of Poorly Differentiated Carcinoma of Unknown Primary Site with Risk of Choriocarcinoma Syndrome Effectively Treated with Reduced Bleomycin,Cisplatin ,Etoposide Combination Regimen(BEP Regimen)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Risk Factors

2018
A Neuroendocrine Tumor of Unknown Primary Origin that Responded to Treatment Based on Tumor Grade Progression.
    Internal medicine (Tokyo, Japan), 2019, Apr-15, Volume: 58, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Hormones; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Somatostatin; Treatment Outcome

2019
Long-term survival of a patient with extensive small cell carcinoma of unknown primary etiology complicated by nephrotic syndrome.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Cranial Irradiation; Edema; Etoposide; Glomerulonephritis, Membranous; Humans; Irinotecan; Lymphatic Metastasis; Neoplasms, Unknown Primary; Nephrotic Syndrome; Paraneoplastic Syndromes; Pleural Effusion, Malignant; Proteinuria; Radiotherapy, Adjuvant; Remission Induction; Tomography, X-Ray Computed

2014
Recurrent Merkel cell carcinoma of the testis with unknown primary site: a case report.
    Journal of medical case reports, 2016, Nov-05, Volume: 10, Issue:1

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Chemotherapy, Adjuvant; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Orchiectomy; Testicular Neoplasms; Treatment Outcome

2016
Gestational choriocarcinoma with renal and pulmonary metastases lacking a primary uterine origin.
    Taiwanese journal of obstetrics & gynecology, 2016, Volume: 55, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Hematuria; Humans; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Methotrexate; Neoplasms, Unknown Primary; Pregnancy; Vincristine

2016
Small cell carcinoma of unknown primary presenting with disease confined to the central nervous system.
    Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Central Nervous System Neoplasms; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiography; Radiotherapy Dosage

2009
"Burned out" testicular seminoma presenting as a primary gastric malignancy.
    International journal of clinical oncology, 2009, Volume: 14, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Diagnosis, Differential; Etoposide; Gastrectomy; Gastroscopy; Humans; Ifosfamide; Immunohistochemistry; Male; Middle Aged; Neoplasms, Unknown Primary; Orchiectomy; Positron-Emission Tomography; Seminoma; Stomach Neoplasms; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography

2009
[Localization of primary small cell carcinoma with liver metastasis: a rare combination of colonic adenocarcinoma and undifferentiated small cell carcinoma].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2002, Volume: 73, Issue:8

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Colectomy; Colon; Colonic Neoplasms; Docetaxel; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Paclitaxel; Taxoids; Time Factors; Vincristine

2002
Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma.
    Acta oncologica (Stockholm, Sweden), 2006, Volume: 45, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease Progression; Etoposide; Female; Humans; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Octreotide; Remission Induction; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome

2006
[Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Survival Rate

2007
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Carcinoma; Chromosome Aberrations; Chromosome Disorders; Cisplatin; Etoposide; Female; Germinoma; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Karyotyping; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prospective Studies; Retroperitoneal Neoplasms; Testicular Neoplasms; Treatment Outcome

1995
Serum cytokine level fluctuations in chemotherapy-induced myelosuppression.
    Japanese journal of clinical oncology, 1996, Volume: 26, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-1; Interleukin-3; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Stem Cell Factor

1996
A case of malignant peritoneal mesothelioma showed complete remission with chemotherapy.
    Japanese journal of clinical oncology, 1998, Volume: 28, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cisplatin; Combined Modality Therapy; Drug Combinations; Etoposide; Female; Humans; Mesothelioma; Neoplasms, Unknown Primary; Peritoneal Neoplasms; Remission Induction; Tegafur; Uracil

1998
Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan, a region with a high prevalence of endemic viral infections.
    Japanese journal of clinical oncology, 1998, Volume: 28, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cisplatin; Drug Administration Schedule; Etoposide; Female; Hepatitis B; Hepatitis C; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Taiwan; Thrombocytopenia; Virus Diseases

1998
Management of patients with cancer of unknown primary site.
    Oncology (Williston Park, N.Y.), 2000, Volume: 14, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Carcinoma; Etoposide; Evaluation Studies as Topic; Female; Humans; Male; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Survival Rate; Taxoids

2000
Carcinoma of unknown primary site.
    Cancer, 2000, Dec-15, Volume: 89, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vomiting

2000
The role of cisplatin/bleomycin-based chemotherapy in the treatment of poorly differentiated carcinoma of unknown primary site.
    Seminars in oncology, 1992, Volume: 19, Issue:2 Suppl 5

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Clinical Protocols; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neoplasms, Unknown Primary; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine

1992
Etoposide/cisplatin-based chemotherapy for patients with metastatic poorly differentiated carcinoma of unknown primary site.
    Seminars in oncology, 1992, Volume: 19, Issue:6 Suppl 13

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Remission Induction

1992
Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas.
    Cancer, 1990, Feb-01, Volume: 65, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Digestive System Neoplasms; Doxorubicin; Etoposide; Female; Genital Neoplasms, Female; Humans; Male; Middle Aged; Mitomycins; Neoplasm Staging; Neoplasms, Unknown Primary; Vincristine

1990
Carcinoma of unknown primary: identification of a treatable subset?
    Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:2

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Unknown Primary

1990